In 2017, Animas Corporation, a subsidiary of Johnson & Johnson Diabetes Care Companies, declared the termination of its Animas Vibe and OneTouch Ping insulin pumps, signifying its departure from the insulin pump industry [85]. Here, INS is linked to diabetes mellitus.